68
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Second Neoplasms Following High-dose Chemotherapy and Autologous Stem Cell Transplantation for Malignant Lymphomas: A Report of Six Cases in a Cohort of 171 Patients from a Single Institution

, , , , , , , , , , & show all
Pages 187-194 | Received 10 Sep 1997, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jonathan Tward, Martha Glenn, Michael Pulsipher, Phillip Barnette & David Gaffney. (2007) Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphoma. Leukemia & Lymphoma 48:8, pages 1482-1495.
Read now
Øystein Bruserud, Nils Glenjen, Bjørn Tore Gjertsen, Lars Herfindal & Stein Ove Døskeland. (2002) Use of marine toxins in combination with cytotoxic drugs for induction of apoptosis in acute myelogenous leukaemia cells. Expert Opinion on Biological Therapy 2:2, pages 197-210.
Read now

Articles from other publishers (20)

Cristina Brickman & Peter Chin-Hong. 2021. Emerging Transplant Infections. Emerging Transplant Infections 833 858 .
K. Heydari, A. Shamshirian, P. Lotfi-Foroushani, A. Aref, A. Hedayatizadeh-Omran, M. Ahmadi, G. Janbabei, S. Keyhanian, E. Zaboli, S. M. Ghasemzadeh & R. Alizadeh-Navaei. (2020) The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis. Clinical and Translational Oncology 22:10, pages 1825-1837.
Crossref
Cristina Brickman & Peter Chin-Hong. 2020. Emerging Transplant Infections. Emerging Transplant Infections 1 26 .
Ayush Naik, Virendra Bhandari, R. Y. Saadvik, K. L. Gupta, Mehlam Kausar & Manika Batra. (2018) Incidence of second primary malignant neoplasm in Malwa region of central India. Journal of Cancer Research and Therapeutics 14:5, pages 999-1004.
Crossref
Stanislav N. Tolkachjov & Jerry D. Brewer. 2018. Skin Diseases in the Immunosuppressed. Skin Diseases in the Immunosuppressed 139 153 .
Sameep Kadakia, Yadranko Ducic, Diego Marra, David Chan, Masoud Saman, Raja Sawhney & Moustafa Mourad. (2016) Cutaneous squamous cell carcinoma of the scalp in the immunocompromised patient: review of 53 cases. Oral and Maxillofacial Surgery 20:2, pages 171-175.
Crossref
Jerry D. Brewer, Tait D. Shanafelt, James R. Cerhan, Timothy G. Call, Amy L. Weaver & Clark C. Otley. (2016) Effect of Non-Hodgkin Lymphoma on Survival in Patients With Malignant Fibrous Histiocytoma, Kaposi Sarcoma, and Sebaceous Carcinoma. Dermatologic Surgery 42:Supplement 1, pages S32-S39.
Crossref
Sai Ravi Pingali & Yago Nieto. 2015. Clinical Guide to Transplantation in Lymphoma. Clinical Guide to Transplantation in Lymphoma 93 102 .
A M VanderWalde, C-L Sun, L Laddaran, L Francisco, S Armenian, J Berano-Teh, F L Wong, L Popplewell, G Somlo, A S Stein, A Nademanee, A Krishnan, N Kogut, S J Forman & S Bhatia. (2012) Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies. Leukemia 27:5, pages 1139-1145.
Crossref
Narendra Hulikal, Satadru Ray, Joseph Thomas & Donald J. Fernandes. (2012) Second Primary Malignant Neoplasms: A Clinicopathological Analysis from a Cancer Centre in India. Asian Pacific Journal of Cancer Prevention 13:12, pages 6087-6091.
Crossref
Agnieszka W. Kubica, Peter S. Rose, Amy L. Weaver & Jerry D. Brewer. (2011) Increased Metastasis of Malignant Fibrous Histiocytoma in Patients With Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma. Mayo Clinic Proceedings 86:8, pages 738-743.
Crossref
Shanmuganathan Chandrakasan, Christine J. Ye, Meera Chitlur, Anwar N. Mohamed, Raja Rabah, Andre Konski, Henry H. Q. Heng & Süreyya Savaşan. (2011) Malignant fibrous histiocytoma two years after autologous stem cell transplant for Hodgkin lymphoma: Evidence for genomic instability. Pediatric Blood & Cancer 56:7, pages 1143-1145.
Crossref
J B Perz, C Giles, R Szydlo, D O'Shea, J Sanz, A Chaidos, S Wagner, J Davis, S Loaiza, D Marin, J Apperley, E Olavarria, A Rahemtulla, I Lampert, K Naresh, D Samson, D MacDonald & E J Kanfer. (2006) LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre. Bone Marrow Transplantation 39:1, pages 41-47.
Crossref
Jonathan D. Tward, Merideth M. M. Wendland, Dennis C. Shrieve, Aniko Szabo & David K. Gaffney. (2006) The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer 107:1, pages 108-115.
Crossref
Thomas J. Kenney & John W. Sweetenham. 2004. Stem Cell Transplantation for Hematologic Malignancies. Stem Cell Transplantation for Hematologic Malignancies 47 84 .
D Genre, P Viens, F Bertucci, C Chabannon, G Gravis, A-C Braud, J Camerlo, G Houvenaeghel, V Moutardier, A Goncalvez, C Protière, V-J Bardou & D Maraninchi. (2002) Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens. Bone Marrow Transplantation 29:11, pages 881-886.
Crossref
I. Barista, F. Cabanillas, J.E. Romaguera, I.F. Khouri, Y. Yang, T.L. Smith, S.S. Strom, L.J. Medeiros & F.B. Hagemeister. (2002) Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?. Annals of Oncology 13:2, pages 318-322.
Crossref
Nabil Saba, Rick Abraham & Armand Keating. (2000) Overview of autologous stem cell transplantation. Critical Reviews in Oncology/Hematology 36:1, pages 27-48.
Crossref
Arnold S. FreedmanDonna NeubergPeter MauchRobert J. SoifferKenneth C. AndersonDavid C. FisherRobert SchlossmanEdwin P. AlyeaTak TakvorianHaddy JallowCaroline KuhlmanJerome RitzLee M. NadlerJohn G. Gribben. (1999) Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma. Blood 94:10, pages 3325-3333.
Crossref
Laura J. Johnston & Sandra J. Horning. (1999) AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA. Hematology/Oncology Clinics of North America 13:5, pages 889-918.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.